Past Colloquia - 2012

Thursday, August 2

Clark Chen, M.D., Ph.D. UCSD Neurosurgery

Jonathan Lynn, M.D., Ph.D. UCSD Pathology

Seth Field, M.D., Ph.D. UCSD Internist

The Academic Track for M.D./Ph.D.s: A panel discussion with early-stage UCSD faculty

Each summer, the Physician Scientist Colloquium hosts faculty panelists to discuss a topic of interest for the physician scientist community. At this event, we have invited early-stage MD/PhD UCSD faculty from a variety of departments to discuss their experiences as academics.  The academic track is one of many available to MSTP graduates, but it is often considered the "default" path.  We hope this event will be informative and will offer current students a deep and honest look at this career path. We look forward to a stimulating discussion from Dr. Chen (Neurosurgery), Dr. Lin (Pathology) and Seth Field (Internal Medicine), moderated by MSTP student Sagar Bapat


Thursday, May 24

Seung K. Kim, M.D., Ph.D. Director of the Stanford MSTP HHMI, Professor of Developmental Biology

Dr. Kim's experiences as a Physician Scientist and the Director of Stanford's MST program

Dr. Seung Kim is a Howard Hughes Medical Investigator and Professor of Developmental Biology at Stanford University.  His research lab has pioneered new approaches to create, expand, and regenerate pancreatic islet cells and also studies pancreatic development and growth.  He is also a graduate of Stanford's Medical Scientist Training Program (1992), AND sixteen years later, in 2008, he became the program's Director! Which one of the current MSTPs will be taking over Paul's position sixteen years from now???


Thursday, March 22

Harry E. Gruber, M.D. Tocagen Inc. President/CEO/Chairman

Research in Progress: Joshua Theisen MSTP student, Kadonaga Lab

Career Perspectives: Experiences in Industry

Dr. Gruber holds a BA and a MD from the University of Pennsylvania. After 9 years at UCSD as a geneticist, rheumatologist and researcher, Dr. Gruber began a career in industry by founding Gensia, Inc. in 1986, one of the earliest gene therapy firms which went public in 1990 and had a market cap of $1.7 billion.  Dr. Gruber founded web-based solutions companies Intervu (sold for 2.8 billion... yes, with a "b") and Kintera (helping non-profits raise money and awareness) in the 90s, and now runs Tocagena company dedicated to the development and commercialization of breakthrough treatments for cancer using advanced gene transfer technologies


Thursday, February 2

Dan Littman M.D. Ph.D. Professor of Molecular Immunology and Professor of Pathology and Microbiology, Howard Hughes Medical Institute Investigator, New York University Langone Medical Center

Research in Progress: Justin Voog, Ph.D. MSTP Student

Career Perspectives: Dan Littman has worked on HIV for nearly 30 years, cloned CD4 while working with Richard Axel at Columbia University, is a giant in the field of T-cell development and biology, and has been an HHMI Investigator for over 20 years at both UC San Francisco and New York University. 


Wednesday, January 18

Paul Mischel, MD Professor of Pathology and Laboratory Medicine, Dept. of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA

Research in Progress: Michael Lam, Ph.D. MSTP Student - Glass Lab

Career Perspectives: Paul Mischel, MD, is the Lya and Harrison Latta Professor of Pathology and Laboratory Medicine at the Department of Molecular and Medical Pharmacology and the David Geffen School of Medicine at UCLA.  Dr. Mischel graduated Alpha Omega Alpha with an M.D. from Cornell University Medical College and trained in Anatomic Pathology and Neuropathology at UCLA.  Dr.Mischel obtained his post-doctoral research training in the laboratory of Dr. Louis F. Reichardt at the Howard Hughes Medical Institute at UCSF and joined the UCLA faculty in 1998.  Dr.Mischel has received a number of awards, including the Farber Award in 2007, the top brain tumor research award given jointly by the Society for Neuro-oncology and the American Association of Neurosurgery. 
Come hear Paul Mischel reflect on his career choices and his perspective on the life of a physician scientist and the biomedical sciences at our next Physician Scientist Colloquium.